Abiopharma

New Form 4 - Black Diamond Therapeutics, Inc. Filed: 2025-06-12 AccNo: 0001415889-25-017048 Size: 5 KB

New Form 4 - Avidity Biosciences, Inc. Filed: 2025-06-12 AccNo: 0001599901-25-000115 Size: 7 KB

New Form 4 - Avidity Biosciences, Inc. Filed: 2025-06-12 AccNo: 0001599901-25-000113 Size: 9 KB

New Form SCHEDULE 13G - KNOW LABS, INC. Filed: 2025-06-12 AccNo: 0001161697-25-000190 Size: 8 KB

PEPG Investor Notice: Robbins LLP Reminds Investors of the Class Action Lawsuit Against PepGen Inc.

New Form SCHEDULE 13D - Quantum Biopharma Ltd. Filed: 2025-06-12 AccNo: 0002072045-25-000002 Size: 145 KB

New Form 4 - MERIT MEDICAL SYSTEMS INC Filed: 2025-06-12 AccNo: 0001415889-25-017043 Size: 14 KB

New Form 4 - Alector, Inc. Filed: 2025-06-12 AccNo: 0000950170-25-085618 Size: 7 KB

New Form 4 - Alector, Inc. Filed: 2025-06-12 AccNo: 0000950170-25-085620 Size: 7 KB

New Form 4 - Alector, Inc. Filed: 2025-06-12 AccNo: 0000950170-25-085614 Size: 7 KB

New Form 4 - Alector, Inc. Filed: 2025-06-12 AccNo: 0000950170-25-085615 Size: 7 KB

New Form 4 - Alector, Inc. Filed: 2025-06-12 AccNo: 0000950170-25-085616 Size: 7 KB

New Form 4 - Alector, Inc. Filed: 2025-06-12 AccNo: 0000950170-25-085617 Size: 7 KB

New Form 4 - Alector, Inc. Filed: 2025-06-12 AccNo: 0000950170-25-085619 Size: 7 KB

Celldex Presents Unprecedented 76 Week Results from Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI Congress 2025